Skip to main content
Loading…

Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 5 May 2021
  6. Current session: 12 May 2021 to 25 May 2025
Answer status
Question type

Displaying 4514 questions Show Answers

|

Question reference: S4W-07081

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 21 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06004 by Nicola Sturgeon on 14 March 2012, whether it is aware of the finding of research conducted on behalf of The Prostate Cancer Charity by Kantar Health in March 2011 that 80% of GPs in Scotland have never heard of the Prostate Cancer Risk Management Programme and what steps it is taking to address this.

Question reference: S4W-06554

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 30 March 2012
  • Current Status: Answered by Fergus Ewing on 18 May 2012

To ask the Scottish Executive what is being done to ensure that businesses in Scotland receive a share of North Sea oil decommissioning work.

Question reference: S4W-07166

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 11 May 2012
  • Current Status: Answered by John Swinney on 17 May 2012

To ask the Scottish Executive what it is doing to promote franchised business.

Question reference: S4W-06555

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 30 March 2012
  • Current Status: Answered by Fergus Ewing on 16 May 2012

To ask the Scottish Executive where the decommissioning of North Sea oil rigs has been carried out since 2002.

Question reference: S4W-07082

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 16 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06002 by Nicola Sturgeon on 8 March 2012, for what reason the draft quality performance indicators for prostate cancer do not include indicators relating to (a) active surveillance, (b) watchful waiting, (c) radiotherapy, (d) chemotherapy, (e) end-of-life care, (f) post-surgical sexual dysfunction, (g) access to clinical nurse specialists or (h) the provision of balanced information on the prostate-specific antigen (PSA) test for men at a higher risk of prostate cancer and whether it considers that the indicators are (i) comprehensive and (ii) provide a single reference point for (A) men with prostate cancer and (B) healthcare professionals.

Question reference: S4W-07083

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 16 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06002 by Nicola Sturgeon on 8 March 2012, what steps it is taking to ensure that men at higher risk of prostate cancer are made aware of the prostate cancer quality performance indicators and that the indicators meet plain English guidelines.

Question reference: S4W-07084

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 16 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06002 by Nicola Sturgeon on 8 March 2012, what its analysis is of The Prostate Cancer Charity’s draft national standards for quality prostate cancer care and whether it will commit to implementing them when they are finalised.

Question reference: S4W-07076

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 15 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06006 by Nicola Sturgeon on 8 March 2012, what representations it received during the formal consultation process for prostate cancer to be included in the Detect Cancer Early Initiative and how the initiative was altered to take account of these representations.

Question reference: S4W-07078

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 15 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06006 by Nicola Sturgeon on 8 March 2012, when it will extend the Detect Cancer Early Initiative to other cancers and on what basis it will decide which cancers to include.

Question reference: S4W-07079

  • Asked by: Mary Scanlon, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 08 May 2012
  • Current Status: Answered by Nicola Sturgeon on 15 May 2012

To ask the Scottish Executive, further to the answer to question S4W-06006 by Nicola Sturgeon on 8 March 2012, how many men have (a) been diagnosed and (b) died of (i) lung, (ii) breast, (iii) bowel and (iv) prostate cancer in each year since 1999.